Literature DB >> 12814914

Cu2+-induced modification of the kinetics of A beta(1-42) channels.

Randa Bahadi1, Peter V Farrelly, Bronwyn L Kenna, Cyril C Curtain, Colin L Masters, Roberto Cappai, Kevin J Barnham, Joseph I Kourie.   

Abstract

We found that the amyloid beta peptide A beta(1-42) is capable of interacting with membrane and forming heterogeneous ion channels in the absence of any added Cu2+ or biological redox agents that have been reported to mediate A beta(1-42) toxicity. The A beta(1-42)-formed cation channel was inhibited by Cu2+ in cis solution ([Cu2+]cis) in a voltage- and concentration-dependent manner between 0 and 250 microM. The [Cu2+]cis-induced channel inhibition is fully reversible at low concentrations between 50 and 100 microM [Cu2+]cis and partially reversible at 250 microM [Cu2+]cis. The inhibitory effects of [Cu2+]cis between 50 and 250 microM on the channel could not be reversed with addition of Cu2+-chelating agent clioquinol (CQ) at concentrations between 64 and 384 microM applied to the cis chamber. The effects of 200-250 microM [Cu2+]cis on the burst and intraburst kinetic parameters were not fully reversible with either wash or 128 microM [CQ]cis. The kinetic analysis of the data indicate that Cu2+-induced inhibition was mediated via both desensitization and an open channel block mechanism and that Cu2+ binds to the histidine residues located at the mouth of the channel. It is proposed that the Cu2+-binding site of the A beta(1-42)-formed channels is modulated with Cu2+ in a similar way to those of channels formed with the prion protein fragment PrP(106-126), suggesting a possible common mechanism for Cu2+ modulation of A beta and PrP channel proteins linked to neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814914     DOI: 10.1152/ajpcell.00147.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  8 in total

Review 1.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

2.  Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity.

Authors:  Gintaras Valincius; Frank Heinrich; Rima Budvytyte; David J Vanderah; Duncan J McGillivray; Yuri Sokolov; James E Hall; Mathias Lösche
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

3.  Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.

Authors:  David C Bode; Mark D Baker; John H Viles
Journal:  J Biol Chem       Date:  2016-12-07       Impact factor: 5.157

4.  α-Synuclein forms non-selective cation channels and stimulates ATP-sensitive potassium channels in hippocampal neurons.

Authors:  Sergej L Mironov
Journal:  J Physiol       Date:  2014-11-13       Impact factor: 5.182

5.  Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy.

Authors:  Ricardo Capone; Felipe Garcia Quiroz; Panchika Prangkio; Inderjeet Saluja; Anna M Sauer; Mahealani R Bautista; Raymond S Turner; Jerry Yang; Michael Mayer
Journal:  Neurotox Res       Date:  2009-03-19       Impact factor: 3.911

6.  Probing structural features of Alzheimer's amyloid-β pores in bilayers using site-specific amino acid substitutions.

Authors:  Ricardo Capone; Hyunbum Jang; Samuel A Kotler; Bruce L Kagan; Ruth Nussinov; Ratnesh Lal
Journal:  Biochemistry       Date:  2012-01-12       Impact factor: 3.162

7.  Ion channel formation by N-terminally truncated Aβ (4-42): relevance for the pathogenesis of Alzheimer's disease.

Authors:  Abhijith G Karkisaval; Agueda Rostagno; Rustam Azimov; Deependra K Ban; Jorge Ghiso; Bruce L Kagan; Ratnesh Lal
Journal:  Nanomedicine       Date:  2020-06-10       Impact factor: 5.307

8.  The amyloid beta ion channel hypothesis of Alzheimer's disease.

Authors:  Najeeb A Shirwany; Daniel Payette; Jun Xie; Qing Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.